NuScale: Optimism vs. Harsh Cash Reality

What happened

NuScale Power's stock has fallen significantly from its 2025 highs, and a recent Motley Fool article stokes long-term optimism by highlighting its regulatory approval and nearing first commercial sale. However, the reality from the latest filings is stark: Q1 2026 revenue was just $0.6M, operating cash burn was $314.7M (driven by a $259.9M payment to partner ENTRA1), and the company relies heavily on ATM equity issuance to fund operations. The critical catalyst—a binding power purchase agreement (PPA) between ENTRA1 and TVA—remains elusive, with NuScale explicitly stating the partnership is non-binding and contingent on such agreements. Fluor's complete exit from its stake removes a supply overhang but also signals loss of a strategic backer, and the company still has $962M in ATM capacity left, posing ongoing dilution risk. While the long-term nuclear thesis is intact, the next 6-9 months hinge on converting non-binding commitments into bankable deals; until then, the stock trades on sentiment and cash-burn trajectory.

Implication

For those with a long-term view, the core nuclear thesis remains intact, but the near-term path is fraught with dilution and cash burn. The absence of a binding PPA means the company is still pre-revenue, relying on ATM equity sales that shrink per-share value. Until a binding offtake agreement is signed, the stock is more a speculative proxy on AI-driven nuclear demand than a de-risked investment. Any position should be sized accordingly, with a clear trigger to exit if cash burn accelerates or PPA timelines slip further. The attractive entry price of $9.50 per the DeepValue analysis offers a margin of safety, but investors must be patient and disciplined.

Thesis delta

The persistent optimism in media contrasts with the lack of binding commercial progress. The thesis remains unchanged: wait for PPA evidence or a lower entry price. The risk of dilution and cash burn continues to outweigh the regulatory moat at current levels.